StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$8.68−0.32 (-3.56%)

Close on Nov 19, 2026Market cap $39.51MP/E –Yield –

Harvard Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Harvard Bioscience's pe ratio was 489.0× on Jul 31, 2015, against 66.9× a year earlier. Over the last 4 years it ranged from 6.2× to 570.0×, with a median of 29.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jul 31, 2015489.0×+375.6
2014Dec 31, 2014113.4×−16.6
2013Oct 31, 2013130.0×+96.3
2012Dec 31, 201233.7×+27.5
2011Dec 30, 20116.2×−10.8
2010Dec 31, 201017.0×–

More Harvard Bioscience figures

See a number that looks wrong?